SAB Biotherapeutics SABS
NASDAQ SABS
$2.91 +0.03 (+1.04%)
As of: Oct 21, 2026 · 11:36 AM EDT

SAB Biotherapeutics (SABS) Preferred Shares (2023 - 2026)

Updated

SAB Biotherapeutics (SABS) recorded Preferred Shares of $62.00 in Q1 2026, compared with $5.00 a year earlier.

Analysis

SAB Biotherapeutics (SABS) Preferred Shares (2023 - 2026) Analysis & Trends

At the end of FY2024, SAB Biotherapeutics reported Preferred Shares of $5.00, unchanged from FY2023.

  • Across earlier years, Preferred Shares came in at $5.00 in FY2023.
  • Quarterly Preferred Shares has ranged from $5.00 in Q4 2023 to $67.00 in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 SAB Biotherapeutics 232.08 Mn -185.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 62.00
Sep 30, 2025 67.00
Jun 30, 2025 5.00
Mar 31, 2025 5.00
Dec 31, 2024 5.00
Sep 30, 2024 5.00
Jun 30, 2024 5.00
Mar 31, 2024 5.00
Dec 31, 2023 5.00
API Access

SAB Biotherapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=SABS&period=max&api_key=YOUR_API_KEY